WHO ICTRP trial
Curcuma longa extract Clinical trial on knee joint health in adult subjects
CTRI/2025/04/084596 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2025/04/084596 |
|---|---|
| Public title | Curcuma longa extract Clinical trial on knee joint health in adult subjects |
| Scientific title | A randomized double-blind placebo controlled clinical study for the comparative evaluation of efficacy and tolerability of Curcuma longa extract in improving knee joint health in adult subjects with mild osteoarthritis - NIL |
| Primary sponsor | Daehan chemtech co., Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: M171- Unilateral primary osteoarthritisof knee |
| Interventions | Intervention1: Curcuma longa extract: Dose: 300mg Dosage form: Capsules Route of administration: Orally Frequency: 1 capsule orally once daily after food Duration:90 Days Control Intervention1: Placebo: Dose: 300mg Dosage form: Capsules… |
| Registration date | Nov 4, 2025 |
| Target size | 150 |
| Secondary IDs | Daehan/Curcuma longa Extract/Joint Health/2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: